2016 Will Be A Big Year For Combo Product Reform, US FDA Says
This article was originally published in Clinica
Questions about the future regulation of combination products came to a head in 2015, and it's likely that significant changes will be put on the table in 2016.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.